339 related articles for article (PubMed ID: 18987104)
21. Multiple sclerosis: magnetization transfer histogram analysis of segmented normal-appearing white matter.
Catalaa I; Grossman RI; Kolson DL; Udupa JK; Nyul LG; Wei L; Zhang X; Polansky M; Mannon LJ; McGowan JC
Radiology; 2000 Aug; 216(2):351-5. PubMed ID: 10924552
[TBL] [Abstract][Full Text] [Related]
22. MRI correlates of cognitive dysfunction in multiple sclerosis patients.
Rovaris M; Filippi M
J Neurovirol; 2000 May; 6 Suppl 2():S172-5. PubMed ID: 10871808
[TBL] [Abstract][Full Text] [Related]
23. Atrophy is detectable within a 3-month period in untreated patients with active relapsing remitting multiple sclerosis.
Hardmeier M; Wagenpfeil S; Freitag P; Fisher E; Rudick RA; Kooijmans-Coutinho M; Clanet M; Radue EW; Kappos L;
Arch Neurol; 2003 Dec; 60(12):1736-9. PubMed ID: 14676048
[TBL] [Abstract][Full Text] [Related]
24. Evolution of focal and diffuse magnetisation transfer abnormalities in multiple sclerosis.
Laule C; Vavasour IM; Whittall KP; Oger J; Paty DW; Li DK; MacKay AL; Arnold DL
J Neurol; 2003 Aug; 250(8):924-31. PubMed ID: 12928910
[TBL] [Abstract][Full Text] [Related]
25. Water content and myelin water fraction in multiple sclerosis. A T2 relaxation study.
Laule C; Vavasour IM; Moore GR; Oger J; Li DK; Paty DW; MacKay AL
J Neurol; 2004 Mar; 251(3):284-93. PubMed ID: 15015007
[TBL] [Abstract][Full Text] [Related]
26. Longitudinal MRI study of multiple system atrophy - when do the findings appear, and what is the course?
Horimoto Y; Aiba I; Yasuda T; Ohkawa Y; Katayama T; Yokokawa Y; Goto A; Ito Y
J Neurol; 2002 Jul; 249(7):847-54. PubMed ID: 12140668
[TBL] [Abstract][Full Text] [Related]
27. [Magnetic resonance in the clinical and therapeutic follow-up of multiple sclerosis].
Rovira-Cañellas A; Alonso-Farré J; Río-Izquierdo J
Rev Neurol; 2000 May 16-31; 30(10):980-5. PubMed ID: 10919200
[TBL] [Abstract][Full Text] [Related]
28. [Magnetic resonance in the diagnosis and treatment of multiple sclerosis].
Rovira Cañellas A
Neurologia; 2000; 15(7):288-302. PubMed ID: 11075577
[TBL] [Abstract][Full Text] [Related]
29. [Involvement of apparently normal white brain substance in the disease process of multiple sclerosis].
Brainin M; Reisner T; Neuhold A; Lang S; Deecke L
Nervenarzt; 1989 Mar; 60(3):159-62. PubMed ID: 2716932
[TBL] [Abstract][Full Text] [Related]
30. [Investigation of involvement of cerebral white matter in DRPLA--including MRI perfusion study].
Mizoi Y; Segawa F; Kamada K; Sunohara N; Nakayama H; Akashi T
No To Shinkei; 1994 Feb; 46(2):145-51. PubMed ID: 8167052
[TBL] [Abstract][Full Text] [Related]
31. Clinical characteristics of children with cerebral white matter abnormalities.
Kristjánsdóttir R; Uvebrant P; Wiklund LM
Eur J Paediatr Neurol; 2000; 4(1):17-26. PubMed ID: 10701100
[TBL] [Abstract][Full Text] [Related]
32. [Magnetic resonance imaging findings of postresuscitation encephalopathy: sequential change and correlation with clinical outcome].
Goto Y; Wataya T; Arakawa Y; Hojo M; Chin M; Yamagata S; Kikuta K; Ishii A
No To Shinkei; 2001 Jun; 53(6):535-40. PubMed ID: 11436337
[TBL] [Abstract][Full Text] [Related]
33. Multiple sclerosis: magnetization transfer MR imaging of white matter before lesion appearance on T2-weighted images.
Pike GB; De Stefano N; Narayanan S; Worsley KJ; Pelletier D; Francis GS; Antel JP; Arnold DL
Radiology; 2000 Jun; 215(3):824-30. PubMed ID: 10831705
[TBL] [Abstract][Full Text] [Related]
34. [Brain atrophy and cognitive disorder in multiple sclerosis].
Pál E; Kosztolányi P; Perlaky P
Orv Hetil; 2002 Dec; 143(48):2681-5. PubMed ID: 12501577
[TBL] [Abstract][Full Text] [Related]
35. [The development of multiple sclerosis following an isolated episode of optic neuritis. Magnetic resonance study].
Río J; Nos C; Rovira A; Tintoré M; Codina A; Montalbán X
Med Clin (Barc); 1997 Sep; 109(10):370-2. PubMed ID: 9379718
[TBL] [Abstract][Full Text] [Related]
36. Clinical and magnetic resonance imaging predictors of disability in primary and secondary progressive multiple sclerosis.
Losseff NA; Kingsley DP; McDonald WI; Miller DH; Thompson AJ
Mult Scler; 1996 Feb; 1(4):218-22. PubMed ID: 9345438
[TBL] [Abstract][Full Text] [Related]
37. Brain atrophy in clinically early relapsing-remitting multiple sclerosis.
Chard DT; Griffin CM; Parker GJ; Kapoor R; Thompson AJ; Miller DH
Brain; 2002 Feb; 125(Pt 2):327-37. PubMed ID: 11844733
[TBL] [Abstract][Full Text] [Related]
38. Pattern and significance of white matter abnormalities in myotonic dystrophy type 1: an MRI study.
Di Costanzo A; Di Salle F; Santoro L; Tessitore A; Bonavita V; Tedeschi G
J Neurol; 2002 Sep; 249(9):1175-82. PubMed ID: 12242535
[TBL] [Abstract][Full Text] [Related]
39. Neurological diseases and accidental falls of the aged.
Syrjälä P; Luukinen H; Pyhtinen J; Tolonen U
J Neurol; 2003 Sep; 250(9):1063-9. PubMed ID: 14504967
[TBL] [Abstract][Full Text] [Related]
40. 18q-syndrome: brain MRI shows poor differentiation of gray and white matter on T2-weighted images.
Linnankivi TT; Autti TH; Pihko SH; Somer MS; Tienari PJ; Wirtavuori KO; Valanne LK
J Magn Reson Imaging; 2003 Oct; 18(4):414-9. PubMed ID: 14508777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
